Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are neurodegenerative diseases with overlapping clinical phenotypes based on impaired motoneuron function. However, the pathomechanisms of both diseases are largely unknown, and it is still unclear whether they converge on the molecular level. SMA is a monogenic disease caused by low levels of functional Survival of Motoneuron (SMN) protein, whereas ALS involves multiple genes as well as environmental factors. Recent evidence argues for involvement of actin regulation as a causative and dysregulated process in both diseases. ALS-causing mutations in the actin-binding protein profilin-1 as well as the ability of the SMN protein to directly bind to profilins argue in favor of a common molecular mechanism involving the actin cytoskeleton. Profilins are major regulators of actin-dynamics being involved in multiple neuronal motility and transport processes as well as modulation of synaptic functions that are impaired in models of both motoneuron diseases. In this article, we review the current literature in SMA and ALS research with a focus on the actin cytoskeleton. We propose a common molecular mechanism that explains the degeneration of motoneurons for SMA and some cases of ALS.
Introduction
The degeneration of motoneurons is a common pathological hallmark of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). While ALS affects upper motoneurons in the cerebral cortex and the brainstem as well as lower motoneurons in the ventral horn of the spinal cord, SMA is characterized by lower motoneuron pathology only. In ALS, symptoms typically develop in advanced adulthood leading to death within months to years after onset, mainly by respiratory failure (Salameh and others 2015) . The clinical phenotypes include lower motoneuron symptoms such as fasciculation and muscular atrophy or upper motoneuron symptoms like spasticity and increased reflexes (Salameh and others 2015) . Different subtypes are discriminated dependent on the earliest observable symptoms: bulbar onset represents a minor fraction of the cases while two thirds of patients display limb onset (Salameh and others 2015) . In SMA, five clinical subtypes can be discriminated dependent on disease onset, survival, and ability of patients reaching certain motor function milestones (Wang and others 2007; Zerres and RudnikSchoneborn 1995) . The most severe SMA type 0, the congenital SMA, has a prenatal onset and is lethal within the first month after birth (Grotto and others 2016) . The most common SMA type, severe SMA type I, is one of the main genetic causes for infant death and patients never reach the ability of sitting without help . Patients suffering from intermediate SMA type II are able to sit but never accomplish walking and most patients reach adulthood (Kaufmann and others 2012) . In juvenile SMA type III, patients with muscle weakness reach the ability of walking with a normal life expectancy (Piepers and others 2008) . Although clinical symptoms are similar for ALS and SMA, the etiologies of diseases largely differ from each other. SMA is a monogenic disease while 90% of ALS cases are sporadic (SALS) and only 10% are hereditary with several genes involved (FALS) (Renton and others 2014) . SMA is caused by mutations or deletion of the Survival of Motoneuron 1 (SMN1) gene (Lefebvre and others 1995) . Severity of the disease is modified by a second gene, SMN2. Although coding for the same protein, SMN2 differs from SMN1 in several base pair exchanges (Lorson and others 1999) . One of those exchanges, a C to T transition within exon 7, is located within an exonic splice enhancer region resulting in only partially spliced SMN mRNA. As a consequence, low levels of functional full-length SMN protein originate from the SMN2 gene (Lorson and Androphy 2000) only partially rescuing a loss of SMN1 in SMA patients. Consistently, the SMN2 copy number inversely correlates with SMA disease severity. Thus, SMA is caused by functional loss of the SMN protein either by low protein levels or by mutated SMN. FALS is mainly inherited in an autosomal dominant manner but there are also autosomal recessive or X-chromosomal-linked heredities (Renton and others 2014) . The main gene alterations with high penetrance are chromosome 9 open reading frame 72 (C9orf72) repeat expansions, or mutations of superoxide dismutase 1 (SOD1), FUS RNA binding protein (FUS), and TAR DNA binding protein (TARDP, (Lattante and others 2015) . Together with other more rarely affected genes they form a group of about 20 genes that cause ALS (Marangi and Traynor 2015) . Moreover, genes and their variants have been identified that do not necessarily lead to ALS but are associated with the disease (van Rheenen and others 2016). Together with high-risk genes they form a group of about 100 genes linked with ALS pathology.
The functions of the genes involved in motoneuron degeneration may point toward the relevant molecular disease mechanism. However, giving the multiple functions of the SMN protein as well as the functional diversity of ALS-associated genes, there is most likely more than one molecular pathomechanism contributing to functional motoneuron impairment. The SMN protein as well as some proteins involved in ALS have been linked to RNA metabolism, and it was suggested that this may be a commonality of the underlying disease mechanisms (Achsel and others 2013) . The strongest link has been reported for FUS, which directly interacts with the SMN protein (Groen and others 2013; Yamazaki and others 2012) . Together, both proteins regulate synthesis of small nuclear RNAs (snRNPs), core components of the spliceosome (Pellizzoni 2007; Tsuiji and others 2013) . However, splicing is a ubiquitous process in all human cells and snRNP assembly can be considered as the housekeeping function of SMN with a possible participation of FUS. To connect perturbations of snRNP biogenesis with preferential motoneuron degeneration, it has been hypothesized that SMN reduction leads to a mis-splicing of a subset of transcripts important for motoneuron survival (Burghes and Beattie 2009) . In addition to their housekeeping functions, SMN and FUS both bind to heterogeneous ribonucleoprotein particles (hnRNPs) involved in axonal mRNA transport pointing to a more specific neuronal role of both molecules (Rossoll and others 2002; Rossoll and others 2003; Wang and others 2015) . Thereby, axonal mRNA is enriched for proteins involved in regulation of cytoskeletal dynamics (Briese and others 2016) .
The importance of the actin cytoskeleton in motoneuron diseases has been underlined by multiple findings. Altered actin dynamics has been reported in model systems of both ALS and SMA (Nolle and others 2011; Oprea and others 2008; Sharma and others 2005; van Bergeijk and others 2007; Wu and others 2012) . Moreover, recent findings in ALS genetics strongly suggest a causal relationship between an altered cytoskeleton and the degeneration of motoneurons rather than being an epiphenomenon: Mutations in Alsin, a regulatory protein of the actin cytoskeleton, have been linked to ALS (Hadano and others 2001; Yang and others 2001) . Moreover, mutations in the profilin-1 gene have been identified as high-risk factors for ALS (Wu and others 2012) . Profilins are major regulators of the actin cytoskeleton, which can bind to the SMN protein providing a molecular link between both motoneuron diseases (Giesemann and others 1999; Nolle and others 2011; Sharma and others 2005) .
In this review, we discuss the current literature about dysregulated actin cytoskeleton in ALS and SMA. Thereby, we hypothesize that a dysfunctional regulatory network with profilin in its center acts upstream of the dynamic cytoskeleton in both motoneuron diseases. Thus, we will start with a description of profilins and their involvement in the regulation of actin dynamics. This will be followed by a comprehensive review about altered actin dynamics and its mechanisms in both diseases. A dysregulation of the actin cytoskeleton is a general mechanism affecting multiple cell types. Indeed, a multisystem character of both diseases has been reported. However, motoneurons are preferentially and commonly affected in ALS and SMA with the highest relevance for the clinical phenotype. Thus, we will conclude this review with a focus on specific molecular and cellular mechanisms of motoneuron degeneration in ALS and SMA. Profilin biology: structural features, actin dynamics, and regulatory mechanisms. (A) Profilin-1 and profilin-2 display similar secondary structures (UniProt ID: P07737, profilin-1; and P35080, profilin-2). Profilin-2 is alternatively spliced leading to two isoforms, canonical profilin-2a (also referred to as profilin-2) and alternative product profilin-2b. (B) Profilin interacts with G-actin and with a lower affinity to F-actin via its actin-binding domain as well as to proteins containing poly-L-proline motifs such as formin, piccolo, and SMN. PIP2 binding close to actin-binding or PLP-binding domains result in a reduced affinity to those residues. (C) A dynamic and localized reorganization of actin is part of almost all cellular motility processes. Actin binds both ATP as well as ADP and possesses an intrinsic ATP hydrolysis activity controlling its dynamic polymerization and depolymerization (Lee and Dominguez 2010) . The filamentous (F-) polymer has a structural polarity with pointed (−) F-actin and barbed (+) F-actin ends. While ATP-bound globular (G)-actin preferentially binds to (+) F-actin ends, ADP-Gactin is released from the (−) F-actin end, resulting in a constant force in direction of the (+) end-a process also called actin treadmilling (Lee and Dominguez 2010) . In living cells most of the G-actin is bound to profilin (Pfn). Profilins are of central importance for actin dynamics, they facilitate ADP to ATP-actin monomer recycling, and binding of actin monomers at the barbed end. Since profilins' affinity of G-actin outreaches barbed(+) end affinity, profilin is released from the barbed end binding another G-actin monomer, thus starting a novel cycle. (D) Profilin activity is regulated by protein phosphorylation at several sites. Src kinase phosphorylates profilin close to the actin-binding domain enhancing its G-actin binding and recycling capacity and increasing F-actin content. Phosphorylation by PKA induces profilin-aggregate formation and phosphorylation of profilin at serine 137 by the Rho kinase (ROCK) reduced its PLP and actin binding capacity. (E) Profilin, cofilin (Cfl), and myosin 2 (Myo2) activities are coordinated by ROCK. ROCK activity (red arrow) results in less profilin and cofilin activity leading to less recycling and actin severing. Myosin-mediated retrograde flow is enhanced. Together, this leads to leading edge retraction or growth cone collapse in a case of a growing neurite.
Profilins contain a binding site for actin, two binding sites for phosphatidylinositol 4,5-bisphosphate (PIP2) (Lambrechts and others 2002) , and poly-L-proline (PLP) binding domains (Fig. 1B) . This allows for localization to membranes, interaction with PLP-containing proteins, and regulation of actin dynamics (Ferron and others 2007; Lee and Dominguez 2010) (Fig. 1C) . Profilins bind monomeric, globular (G-) actin thereby regulating its polymerization to filamentous (F-) actin. F-actin polymerization is an important cellular mechanism of force production being involved in diverse cellular motility and transport processes important for proper motoneuron function (Fig. 1C) .
Profilin has a dual effect on F-actin formation (Shekhar and others 2016; Yarmola and Bubb 2009) : profilin binding to actin monomers in conditions with relatively high profilin concentrations sequesters actin monomers dissociating from the filament, thereby inhibiting F-actin formation (Carlsson and others 1977) . Moreover, profilin does not only bind G-actin but also facilitates ADP-Gactin to ATP-G-actin exchange, thus acting as a catalytic converter for actin monomer recycling (Mockrin and Korn 1980) . This profilin-bound ATP-G-actin can be added to the barbed end of the filament (Pring and others 1992) and consecutive profilin dissociation from the filament-bound actin is necessary for further elongation (Nyman and others 2002) (Fig. 1C) . This effect can also be nominated a transient capping of the barbed end. In cell free in vitro assays with excess profilin concentrations both processes, monomer-sequestration together with cap-formation, contribute to F-actin depolymerization. However, in living cells profilin can also stabilize F-actin (Cao and others 1992; Finkel and others 1994) . In cells, the majority of G-actin is bound to profilin, and it was suggested that a relatively high amount of readily available profilin-bound G-actin together with profilin uncapping contributes to its role in promotion of actin polymerization (Yarmola and Bubb 2009) (Fig. 1C) .
In the cellular context, profilin is part of a complex regulatory network and several mechanisms contribute to its regulation. First, competitive binding with other barbed end binding proteins may be important for profilin function and actin dynamics (Pernier and others 2016) . Second, profilin's poly-L-Proline (PLP) binding domain mediates the interaction with several profilin ligands (Fig. 1B) . Those include actin binding proteins such as formins (Jockusch and others 2007) , which controls the length of actin filaments by catalyzing profilin-actin association at the barbed end (Romero and others 2004) . Another class of profilin ligands mediate cell-specific motility processes such as piccolo, which is important for synaptic vesicle cycling in neurons (Waites and others 2011; Wang and others 1999) . Moreover, the SMN protein directly interacts with profilin via its PLP domain (Giesemann and others 1999; Nolle and others 2011) . Since profilin-2 exhibits a stronger affinity to PLP domains compared to profilin-1 (Nodelman and others 1999) , it is not surprising that the SMN-profilin-2 interaction was more pronounced than the SMN-profilin-1 interaction (Giesemann and others 1999) . Third, profilin can not only bind to actin or PLP but also to phosphatidylinositol 4,5-bisphosphate (PIP2) at the membrane (Goldschmidt-Clermont and others 1990). PIP2-bound profilin may have a reduced affinity for PLP as well as actin and thus be inactive with regard to actin polymerization (Lambrechts and others 2002) (Fig. 1B) . Instead, it may interfere with PIP2-dependent signaling pathways such as the PI3K/Akt pathway (Bae and others 2010) . Finally, another layer of complexity comes with the posttranslational modifications of profilin, which is phosphorylated at multiple sites (Fig. 1C) . Protein kinase A (PKA) phosphorylates profilin-1 at threonine residue 89 inducing protein instability, profilin-actin rich aggregates, and reduction in F-actin content (Gau and others 2016) . VEGF receptor kinase-2 and the non-receptor tyrosine kinase Src phosphorylate profilin-1 close to the actin-binding domain, thereby enhancing actin binding and recycling, finally inducing F-actin formation (Fan and others 2012) . Moreover, the RhoA kinase (ROCK) phosphorylates profilin-1 at Ser137 close to the PLP-binding domain inhibiting its PLPbinding capacity (Shao and others 2008) and to a lesser extent its G-actin binding (Diamond and others 2015; Shao and others 2008) . In neurons, ROCK directly interacts with profilin-2, resulting in stabilization of F-actin and a reduction in neurite outgrowth (Da Silva and others 2003; Witke and others 1998) .
ROCK is an important upstream factor that coordinates the activity of an actin regulatory network containing profilins (Fig. 1D ). Besides profilin, ROCK directly or indirectly phosphorylates several targets including cofilin and myosin-2, thereby controlling actin-based force generation. Cofilin is an F-actin severing protein with a dual outcome: F-actin severing leads to an increase in barbed (+) ends enhancing polymerization rate of readily available ATP-G-actin (Sarmiere and Bamburg 2004) . In contrast, enhancing cofilin activity without enhancing actin recycling induces filament breakdown with less F-actin (Gomez and Letourneau 2014) . Thus, a fine coregulation of profilin and cofilin activity is needed for actin treadmilling and ROCK activity inhibits profilin's recycling activity as well as cofilin's F-actin severing activity (Arber and others 1998; Edwards and others 1999; Maekawa and others 1999; Sarmiere and Bamburg 2004) . Myosin motor proteins participate in actin-based force generation. Myosin-2 facilitates retrograde flow of actin filaments from the periphery of the neuron to the center thereby promoting filament breakdown and G-actin recycling at the pointed (−) end (Lin and others 1996; Medeiros and others 2006) . ROCK directly phosphorylates the regulatory chain of myosin-2 . Moreover, ROCK phosphorylates and thereby inhibits myosin light chain phosphatase (MLCP) activity (Kawano and others 1999; Kimura and others 1996) . This leads to an enhanced myosin-2 activity resulting in an increase of retrograde flow and a subsequent growth cone collapse (Jalink and others 1994; Zhang and others 2003) . Thus, ROCK activation facilitates a coordinated retraction of the growth cone by (1) induction of retrograde flow through myosin-2 phosphorylation, (2) reduction of free barbed (+) ends by inhibition of cofilindependent actin severing coupled with (3) a less dynamic F-actin through profilin inactivation.
The Actin Cytoskeleton in Motoneuron Diseases
Although there is growing evidence showing involvement of the actin cytoskeleton in motoneuron diseases based on human genetics and experimental models, only little is known about the situation in patients. Of course, this is due to the difficult accessibility of the human in vivo situation for the evaluation of the dynamic properties of the actin cytoskeleton. However, postmortem analyses may permit a static evaluation. Actin-containing neuronal inclusions in Guam ALS patients, the Hirano bodies, have been known for a long time (Hirano 1994) . Those structures were possibly detected because they become visible in neuropathological evaluations. Hirano bodies are partially ordered, paracrystalline cytoplasmic inclusions that additionally contain actin-associated proteins (Galloway and others 1987; Goldman 1983; Schochet and McCormick 1972) . However, their contribution to the disease is still under debate, and in principle, they could either be a toxic aggregate or an epiphenomenon pointing toward a functional loss of the dynamic properties of actin.
The Actin Cytoskeleton in SMA
In SMA, the first hints for an involvement of the actin cytoskeleton came from crosslinking experiments identifying profilins as potential interactors of the SMN protein (Giesemann and others 1999) . Thus, profilin-1 displayed a much weaker SMN-binding compared to profilin-2. This interaction has been verified by different in vivo methods and localized to the second proline stretch within the SMN protein (Nolle and others 2011) . Since profilin-2 is mainly expressed in nervous tissue, this finding offered an explanation for the preferential degeneration of neuronal cells in SMA. Indeed, patient-derived fibroblasts and HEK293 cells with an SMN knockdown did not show altered actin dynamics (Nolle and others 2011; Oprea and others 2008) . Functional studies employing in vitro actin polymerization assays examined the involvement of the SMN protein in the regulation of actin dynamics. While recombinant SMN had no influence on actin polymerization it could protect F-actin from urea destabilization indicating a direct and stabilizing interaction with F-actin (Sharma and others 2005) . This is an important finding; however, a direct interaction of SMN and F-actin has not been verified yet and the functional consequences are unknown so far. Additionally, the functional interaction of profilin-2 and SMN was examined in this study. Profilin-2 binds to actin monomers, thereby reducing actin polymerization in absence of SMN. This represents its sequestering and transient capping activity (Sharma and others 2005) . Interestingly, SMN partially counteracts this effect resulting in more F-actin and indicating a reduced sequestering activity of profilin when bound to SMN (Sharma and others 2005) . However, regulation of profilin at the barbed end comprises a major regulatory mechanism of its activity (Pernier and others 2016) . Therefore, this effect could also be explained by a modulatory activity of SMN on profilin's transient actin-capping activity. SMN possibly accelerates the release of profilin from the barbed end after profilin-bound ATP-Gactin has been attached to the filament. Although the precise mechanism of this SMN activity is unclear, it means that in conditions of SMN reduction, conditions such as SMA, a loss of profilin function with regard to F-actin formation is expected.
However, in living cells the PLP binding domain of profilin may become more accessible when SMN levels are reduced (Fig. 2 ). This may be the case for other profilin ligands and for profilin phosphorylation at the PLP domain. Indeed, a significant profilin hyperphosphorylation at multiple sites could be observed by 2D gel electrophoresis both in vitro and in spinal cords of an SMA mouse model (Nolle and others 2011) . Moreover, an SMN knockdown induced a stronger interaction between profilin-2 and its upstream kinase ROCK (Bowerman and others 2007) . Those findings resulted in a competitive model where profilin-2 is released from SMN in SMA, binds to ROCK, becomes hyperphosphorylated and deactivated with regard to actin and PLP binding. ROCK binding to cofilin and myosin light chain phosphatase (MLCP) is in turn reduced leading to a reduced phosphorylation (Nolle and others 2011) (Fig. 2) . The reduction in cofilin phosphorylation in SMA hints for an enhanced actin severing activity. A reduced actin monomer recycling together with an enhanced actin severing activity would lead to less F-actin (Fig. 1E) . Indeed, this was reported in several studies employing astroglioma cells (Caraballo-Miralles and others 2012), SMA mice neuromuscular junctions (NMJs) (Ackermann and others 2013) , HEK293 cells as well as motoneuron-like NSC34 cells (Hosseinibarkooie and others 2016) . However, a reduction in MLCP phosphorylation has been additionally observed in another model system (Nolle and others 2011) . This would result in a reduced myosin-2 activity leading to a reduction in retrograde actin flow. As retrograde flow promotes depolymerization of F-actin within the central domain of the growth cone, reduced MLCP phosphorylation argues for enhanced levels of F-actin. Indeed, more F-actin and less G-actin have been observed in a neuronal cell line with a knockdown for SMN as well as in growth cones of primary SMA motoneurons (Nolle and others 2011; van Bergeijk and others 2007) . Thus, it may be the specific cellular context determining which processes become dominant: either the reduced monomer recycling together with an enhanced actin-severing activity or the reduced retrograde flow. A simple measurement of F/G-actin ratios within whole cell lysates or the whole growth cones may be sufficient to demonstrate the presence of an altered steady-state but not the dynamic characteristics of the actin dysregulation.
However, an intermediate SMA mouse model with homozygous profilin-2 depletion displayed a tendency for a reduced weight gain as well as a reduced survival compared to SMA mice with two alleles of profilin-2 (Bowerman and others 2009). Thus, a knock-out aggravates the phenotype indicating the importance of functional profilin-2 in motoneuron survival. Moreover, transfection of the phosphomimetic profilin-2 mutant S137D, a potential ROCK phosphorylation site, revealed a marked reduction in neurite lengths compared to phosphorylation-resistant mutant S137A (Nolle and others 2011) . This not only mimics the effects of an SMN protein loss but also demonstrates a phosphorylation-dependent loss of profilin-2 function in the context of neuronal actin dynamics. Supporting the relevance of the ROCK pathway, treatment of intermediate SMA mice with specific ROCK inhibitors ameliorated survival and motor functions (Bowerman and others 2010; Bowerman and others 2012) . However, the precise nature of the altered phosphorylation pattern of profilin-2 in SMA has not been fully characterized yet. It is still unknown which phosphorylation sites are affected. Regarding upstream mechanisms, it is unclear whether ROCK is the only kinase involved in altered profilin phosphorylation. Regarding downstream mechanisms, the functional connection between phosphorylation of profilin in SMA and its interaction with profilin ligands, its actin-binding, transient capping and recycling properties has not characterized in detail yet.
The Actin Cytoskeleton in ALS
Interestingly, a functional loss of profilin function as a mechanism in motoneuron diseases has recently been supported by findings in ALS. Exome capture with deep sequencing led to the identification of profilin-1 as a novel gene in familial ALS with dominant inheritance (Wu and others 2012) (Fig. 3, Table 1 ). Linkage analysis and comparisons with unaffected control samples suggested a causal relationship with a high penetrance of most profilin-1 mutations (Wu and others 2012) . However, mutants with only a modest penetrance have also been reported arguing more in favor of a risk factor (Fratta and others 2014; van Blitterswijk and others 2013; Wu and others 2012) . Different point mutations have been reported directly located at the actin binding site or in close proximity. Also, mutated residues locate proximal to the PLP binding site as well as to the center of the protein (Fig. 3) . Interestingly, ALS patients with profilin-1 mutations exhibit a limb onset with predominant lower motoneuron pathology similar to SMA (Table  1) . With regard to functional analysis in model systems, many of the results were obtained using plasmids that encoded tagged profilin mutants. Since profilin is a small protein and small tags can completely abolish their binding to the PLP domain (Lambrechts and others 2002) those results have to be interpreted with caution (Table 1) .
In principle, the pathomechanism can either be a gainof-toxicity or a loss-of-function mechanism and both have been suggested for ALS-linked profilin-1 mutations. Mutated profilin-1 forms aggregates in cells that contain TDP-43 but no FUS or SMN (Smith and others 2015; Wu and others 2012) . Moreover, cells transfected with mutant profilin-1 results in insoluble profilin-1, which induced TDP-43 positive aggregates in non-transfected cells indicating a prion-like character of those aggregates (Tanaka and Hasegawa 2016) . Those results argue in favor of a gain-of-toxicity mechanism. However, a sequestration of profilin in aggregates may also largely impair profilin function with regard to the regulation of actin dynamics. A relatively simple mechanism of a functional loss has been proposed using different stability assays. Profilin-1 mutants were more susceptible to denaturation conditions and displayed an enhanced turnover rate in neuroblastoma cells (Boopathy and others 2015) . More specifically, a loss of a novel profilin function has been associated with ALS-causing mutations: profilin-1 and 2 localize to stress granules while profilin-1 ALS mutants were either not recruited to stress granules or accumulated in aggregates (Figley and others 2014) . Thus, altered stress granule dynamics induced by profilin-1 mutants was suggested as a critical function for disease development.
A profilin-1 mutation at a putative phosphorylation site has also been reported in ALS (Ingre and others 2013) . This is in accordance to a proposed mechanism of profilin hyperphosphorylation at multiple sites leading to its functional inactivation in SMA (Nolle and others 2011) . Interestingly, this mutant could bind actin; however, its PLP binding properties or an involvement in altered decapping have not been analyzed yet (Freischmidt and others 2015) . Some ALS-linked profilin-1 point mutations localize proximal to actin-binding sites and one mutation is directly localized to this domain (Fig. 3) . Not surprisingly, this mutant exhibited a lower affinity for actin. This points toward a loss-of-function mechanism directly related to actin dynamics. Supporting this, cells transfected with this mutant had less F-actin and a reduced growth cone area (Wu and others 2012) (Table 1) . Recently, transgenic mice were generated harboring the C71G as well as the G118V mutations, which are both close to the actin-binding domain (Fil and others 2016; Yang and others 2016) . Those mice expressed V5 tagged PFN1 C71G or tagged free PFN1 G118V under the control of a neuronal promotor and displayed a reduced survival, weight, and motor functions, loss of motor and sensory axons, and neuromuscular junction denervation (Fil and others 2016; Yang and others 2016) . In PFN1 C71G mice, the ALS-like pathophysiology Mutations are listed with clinical representation giving the type of onset and the age. The position of the mutation within the protein is shown in Figure 1 in detail and summarized here. Notably, specifications for the location describe proximity to the actin binding or the PLP-binding site. However, G118V is directly located at the actin binding site. Functional impairments in comparison with wildtype profilin has been semiquantitatively described by +++ for a huge impairment, ++for an intermediate effect, + for a relatively small effect, and − if there was no impairment. There is not always a consistent relationship between the position and the type of functional impairment indicating allosteric alterations. M114T at the center of the protein displays a reduced actin-binding but does not sequester G-actin. However, G118V, which is directly located at the actin binding site, results in a consistent dysregulation of the actin cytoskeleton with a reduced F/G-actin ratio reported in two different studies (Freischmidt and others 2015; Wu and others 2012) . Note that some of these results were obtained with tagged profilin-1 possibly impairing its interaction with other proteins (Lambrechts and others 2002) .
was dose dependent since homozygous expression of the transgene aggravated the symptoms. Interestingly, protein aggregates could only be detected after symptom onset, indicating that this gain-of-toxicity mechanism may not be the primary cause of motoneuron degeneration in PFN1 C71G mice (Yang and others 2016) . Moreover, PFN1 G118V mice displayed a reduced F/G-actin ratio within motoneurons at disease onset and a tendency for a reduction at presymptomatic stages indicating an involvement of changed actin dynamics in motoneuron degeneration (Fil and others 2016) . However, further experimental work is needed to clarify which profilin function contributes to which extent to the development of ALS symptoms: its unconventional role in stress granule formation, its tendency to form aggregates, or a dysregulated actin cytoskeleton. Giving the molecular similarities of profilin-linked ALS and altered actin dynamics in SMA, the question arises why SMA is based on profilin-2 alterations while ALS mutations have been only identified in profilin-1 so far. First, it cannot be excluded that profilin-1 alters actin dynamics in SMA at least partially. Although the SMN association of profilin-1 seems to be much weaker compared to profilin-2 at a first glance (Giesemann and others 1999) , the amount of profilin-1 bound SMN compared to profilin-2 bound SMN has not been evaluated yet. Second, ALS linked profilin-1 mutations are rare compared to other FALS mutations (Chen and others 2013; Lattante and others 2015; Tiloca and others 2013; van Blitterswijk and others 2013; Zou and others 2013). The fact that profilin-2 mutations have not been identified in a screening of 274 FALS patients is relativized by the low abundance of profilin-1 mutations in this cohort-only 7 patients displayed alterations of this gene (Wu and others 2012) . Profilin-1 and -2 display largely overlapping functions with regard to their basic properties (Jockusch and others 2007). The major difference seems to be the expression profiles. Profilin-1 is ubiquitously expressed including the CNS while profilin-2 expression is restricted to the CNS only (Jockusch and others 2007) . Thus, both proteins are expressed in the CNS while non-CNS tissues express Pfn1 only. Consistently, Pfn1-/-mice die early in embryonic development (Witke and others 2001) , possibly because of a lack of profilin in non-CNS tissue. Pfn2-/-mice have only mild CNS phenotypes. They are normal in CNS development, have no memory phenotypes, and have no overt motor impairments (Pilo Boyl and others 2007) . These results indicate a compensation of Pfn2-loss by Pfn1 in the CNS and a redundancy between profilin-1 and profilin-2 in the CNS. The only detectable phenotype was an increased novelty seeking behavior indicating very specific functions exclusively performed by profilin-2 (Pilo Boyl and others 2007). However, profilin-2 is expressed in motoneurons (Bowerman and others 2009) and it still remains to be elucidated which particular functions are linked to profilin-2 in those cells. In the CNS, both proteins have been linked to the synapse-an early affected structure in motoneuron diseases.
Plastin-3: A Genetic Modifier in SMA
Another modulator of actin dynamics and SMA severity has been identified in discordant siblings displaying affected and non-affected individuals with the same SMN2 copy number. A transcriptome screening revealed an enhanced expression of plastin-3 in non-affected siblings (Oprea and others 2008) . Plastin-3 (t-plastin) is an actin-bundling protein comprising a calcium-binding and several actin-binding domains (Delanote and others 2005) . The coding gene is located on the X-chromosome and the gene dose may be critical for modification capacity: All of the unaffected siblings were females (Oprea and others 2008) . Although not all discordant female siblings displayed an enhanced plastin-3 expression (Bernal and others 2011) , a correlation between disease severity and plastin-3 transcript levels could be verified (Stratigopoulos and others 2010 (Heesen and others 2016) . However, another fact argues against plastin-3 expression as a mediator of SMA pathology: Human subjects with plastin-3 mutations leading to a complete or an almost complete protein loss do not develop signs of lower motoneuron degeneration but osteoporosis (Fahiminiya and others 2014; van Dijk and others 2013) . Moreover, a direct interaction of plastin-3 with SMN has not been shown so far raising the question of how plastin-3 affects SMA on the molecular level. Although a direct involvement of plastin-3 expression in the SMA pathomechanism cannot be completely ruled out, we suggest an alternative model in which plastin-3 compensates for pathological alterations in actin dynamics induced by a functional loss of profilin. This function may be independent of plastin-3 bundling activity. Interestingly, plastin-3 can not only bundle actin filaments but is also involved in regulation of actin turnover (Giganti and others 2005) . These effects are independent of each other since the actin-binding domain 1 (ABD1) of plastin-3, which does not bundle filaments, is capable of stabilizing F-actin in cell-free experiments as well as in cells (Giganti and others 2005) . Moreover, plastin-3 is capable to counteract the actin depolymerization activity of cofilin (Giganti and others 2005) and-more important-profilin (Kovar and others 2000) . Since SMN also counteracts profilin depolymerization in a similar way, plastin and SMN display redundant effects with regard to regulation of actin dynamics by profilin (Giganti and others 2005; Kovar and others 2000; Sharma and others 2005) . Accordingly, motor axon defects of SMA Zebrafish could be ameliorated by plastin-3 overexpression independent of its actin bundling or actin-binding properties (Lyon and others 2014) . However, those effects were dependent on the EF hand motif of plastin-3, which undergoes conformational changes on Ca 2+ binding (Lyon and others 2014) . Additionally, plastin-3 could ameliorate F-actin reduction in patient cells as well as neurite outgrowth defects in primary motoneurons from SMA mice and zebrafish treated with a smn antisense morpholino (Oprea and others 2008) . Moreover, plastin-3 expression partially rescued neuromuscular junction phenotypes and motor functions in SMN-depleted Zebrafish while there was no effect on survival (Lyon and others 2014) . Similarly, plastin-3 overexpression in severely affected SMA-mice ameliorated several histopathological alterations such as neuromuscular junction (NMJ) phenotypes, loss of central synapses at motoneurons, and muscle fiber size, but did not influence pathophysiological outcomes like survival, weight, and motor functions. However, plastin-3 overexpression has an impact on the pathophysiology in milder SMA mice (Ackermann and others 2013), which results in an impressive effect in intermediate SMA mice (Hosseinibarkooie and others 2016) .
Actin and Disease Phenotypes
Diverse phenotypes in motoneuron diseases can be linked to changes in cellular motility processes. This includes altered sprouting, neurite outgrowth, synaptic vesicle dynamics, as well as stability or instability of the synapse (Fig. 4) . Actin is a major regulator of these processes providing a link between the molecular mechanisms with cellular and clinical phenotypes. In the following paragraph, we will summarize each of those phenotypes clarifying the already described as well as the missing links to the actin cytoskeleton.
Axonal Sprouting and Branching
The formation of axon collaterals follows diverse mechanisms that all involve regulation of focal F-actin polymerization as an initial step (Gallo 2011) (Fig. 4C ).
This includes preexisting axonal actin filament patches that serve as potential branch points and become lateral filopodia during ramification events (Lau and others 1999) . Subsequently, those structures maturate by invasion of microtubules (Yu and others 1994) . The actinbased initiation involves the formation of actin bundles and the suppression of ROCK activity (Loudon and others 2006) . Thus, ROCK can be regarded as a factor keeping axonal maintenance. Vice versa, ROCK inhibition resulted in an enhanced lifespan of actin filament patches and enhanced the probability of an actin patch to form a filopodium-a mechanism mediated by myosin-2-based retrograde flow (Loudon and others 2006) . Moreover, ROCK induced phosphorylation of profilin-2 was suggested to suppress branching (Da Silva and others 2003). Thus, profilin-2 hyperphosphorylation argues for sprouting deficiencies in SMA. Axonal sprouting or terminal sprouting in motoneurons is a compensatory mechanism for loss of motoneuron terminals in normal aging or in early phases of motoneuron diseases (Gordon and others 2004) . Finally, this leads to an expansion of the motor unit in ALS (Dengler and others 1989; Shefner and others 2011) and SMA patients (Dengler and others 1989; Gawel and others 2015; Kang and others 2014; Swoboda and others 2005) . Interestingly, an SMA mouse model displayed a reduced number of terminal sprouts after botulinum toxin-induced paralysis demonstrating a general sprouting deficiency (Murray and others 2013) . Thus, secondary to motoneuron loss, a reduced compensatory capacity may further contribute to the disease progression. This mechanism may be based on altered actin dynamics by profilin. However, Zebrafish embryos display an abnormal branching, which may be more an axonal maintenance deficit (McWhorter and others 2003) . Interestingly, these defects could be rescued by plastin-3 overexpression stressing the importance of actin dynamics in this process (Oprea and others 2008) . Although neurite maintenance during development and sprouting as a reaction to denervation may mechanistically be very different processes, both may share basal mechanisms such as a focal regulation of actin dynamics. Also, both processes rely on formation of a growth cone and subsequent neurite outgrowth.
Neurite Outgrowth
In addition to ramification processes, terminal sprouting involves axonal outgrowth: After terminal branching, a growth cone forms guiding the newly formed branch to a neighboring neuromuscular junction (Torigoe 1988) . A partial deactivation of profilin leads to motor axon outgrowth deficiencies indicating that proper function of the growth cone and neurite outgrowth relies on profilin (Kim and others 2001) . The growth cone is one of the best studied neuronal models for actin dynamics and its regulation by ROCK (Fig. 4A) . Alterations can be easily measured at the cellular level by accessing morphological parameters such as the growth cone area or neurite lengths. In ALS and SMA, several studies Figure 4 . The actin cytoskeleton in healthy and diseased motoneurons. Profilin-based regulation of the actin cytoskeleton is involved in different processes relevant for motoneuron diseases. In SMA, loss of profilin function is associated with its hyperphosphorylation. In ALS, different mutants may affect diverse functions of profilin such as poly-L-proline (PLP) or actin binding. (A) At growth cones, profilin facilitates actin monomer binding to the barbed F-actin ends in the peripheral (P) domain. Cofilin cleaves F-actin and enhances the number of barbed ends eventually promoting F-actin dynamics in concert with profilin. Myosin light chain phosphatase (MLCP) regulates retrograde F-actin flow participating in force generation. This regulatory network is controlled by Rho kinase (ROCK) as a signal hub. In SMA, ROCK induces hyperphosphorylation of profilin while MLCP and cofilin become less phosphorylated. This dysregulation results in an altered F-actin content and a growth cone arrest with reduced neurite outgrowth. (B) At the postsynapse, profilin binds to gephyrin linking receptor clustering with actin dynamics. Additionally, profilin is enriched in the activated postsynapse mediating synaptic stability. In SMA and ALS, synaptic stability is impaired leading to a central synapse loss. (C) Branching depends on de-phosphorylated profilin inducing focal actin polymerization as an initial step in branch formation. In SMA and ALS, dysfunctional or phosphorylated profilin fails to induce branching. (D) At the presynapse of the neuromuscular junction, endocytosis and synaptic vesicle cycling depend on regulated actin dynamics. Dynamin-1 and profilin directly interact via PLP domain inducing small F-actin filaments along the endocytosed vesicle. In SMA, phosphorylation impairs this interaction preventing efficient endocytosis. In active zones, piccolo forms a complex with profilin resulting in a polymerization of F-actin. This serves as a scaffold for myosin-based synaptic vesicle movements refilling the recycling pool and transporting vesicles from the recycling pool to the membrane. In SMA and ALS, dysfunctional profilin abrogate efficient synaptic vesicle transport.
analyzed those outcomes for different model systems linking them with altered actin dynamics (Hao le and others 2012; Lyon and others 2014; Nolle and others 2011; Oprea and others 2008; Tudor and others 2005; van Bergeijk and others 2007; Wu and others 2012) . The growth cone is a highly organized structure with a peripheral (P) and a central (C) domain (Gomez and Letourneau 2014) . F-actin bundles and meshwork locate to the P-domain forming filopodia and lamellipodia. The central domain is largely devoid of actin but contains microtubules. In general, F-actin assembles at the P-zone and becomes retrogradely transported to the transition (T) zone between C-and P-domains where it disassembles. This process produces a force pushing the growth cone forward. Experiments with actin-depolymerizing agents demonstrated that actin-based force generation is not essential for protrusion indicating an important role for microtubules (Marsh and Letourneau 1984) . However, without actin, neurite outgrowth was slower and growth cones were not responsive to guidance cues. ROCK generally promotes growth cone collapse inhibiting neurite outgrowth and is a mediator of several repulsive guidance cues (Dontchev and Letourneau 2003) . ROCK directly and indirectly phosphorylates (1) profilin, reducing F-actin turnover; (2) cofilin, reducing F-actin severing and free barbed end abundance; and (iii) enhancing myosin-2-based retrograde flow. Thus, F-actin is stabilized and transported to the central domain. Accordingly, total F-actin levels at the growth cone are only slightly reduced or remain unchanged, but actin relocates to the C-domain (Gallo and Letourneau 2004; Gallo and others 2002) . This demonstrates that total F-actin levels are not necessarily linked to changes of cellular behavior. In SMA and ALS, F/G-actin levels were altered at the growth cone indicating a drastic dysregulation (Nolle and others 2011; Wu and others 2012) . Moreover, inhibition of ROCK may be a possibility to induce dynamic properties of F-actin and to counteract functional profilin loss induced by its hyperphosphorylation. Indeed, ROCK inhibition rescued neurite outgrowth deficiencies observed in SMA in vitro models (Nolle and others 2011) . The involvement of small GTPases upstream of the ROCK pathway has also been suggested for ALS: Loss-of-function mutations in the ALS2/Alsin gene causes a juvenile form of ALS (Hadano and others 2001; Yang and others 2001) . Interestingly, Alsin functions as a Rac guanine nucleotide exchange factor (Rac-GEF) and positively regulates neurite outgrowth, indicating an opposite effect compared to ROCK (Topp and others 2004; Tudor and others 2005) . Thus, Alsin loss of function in ALS and dysregulations of the ROCK pathway in SMA may have similar effects on the neuronal cytoskeleton.
Synaptic Vesicle Mobilization
Synaptic dysfunction is a common mechanism of SMA and ALS and includes degeneration of the neuromuscular junction as well as central synapses at the motoneuron cell body (Murray and others 2010) . The pre-symptomatic incidence of NMJ-phenotypes in human SMA fetal muscle as well as in ALS mouse models indicates an important role in disease progression (Fischer and others 2004; Martinez-Hernandez and others 2013) . This argues for a dying back mechanism with distal motoneuron pathology. However, also central synapse loss has been observed in SMA and ALS (Ling and others 2010; Mentis and others 2011; Nagao and others 1998) . Importantly, an expression of SMN in motoneurons rescued the NMJ degeneration as well as the central synapse loss indicating presynaptic mechanisms at the NMJ and postsynaptic mechanisms at the central synapses (Gogliotti and others 2012; Martinez and others 2012) . SMN and profilin are pre-and postsynaptic proteins localizing to synaptic vesicles (SVs) (Fan and Simard 2002; Murk and others 2012; Pagliardini and others 2000) . Moreover, actin is highly enriched in the pre-and postsynaptic compartments indicating an important functional role (Cingolani and Goda 2008) . At the presynapse, Ca 2+ influx initiates rapid exocytic fusion of SVs releasing neurotransmitters into the synaptic cleft. SVs in the presynapse are subdivided into functionally distinct pools (Cingolani and Goda 2008) : SVs in the readily releasable pool are primed and docked to the membrane. However, the majority of SVs is part of the recycling and reserve pools and the intensity of neurotransmitter release can be regulated by shuttling between those pools. In the presynapse, actin controls SV shuttling between different pools, SV exocytosis, and SV recycling via endocytosis (Fig. 4D) .
With regard to SV shuttling and exocytosis, actin may have a dual function: It could guide SVs to the membrane enhancing the size of the readily releasable pool (Lee and others 2013) or F-actin could form a barrier sequestering SVs from the membrane and inhibiting their release (Cingolani and Goda 2008) . Thus, opposing effects on vesicle release have been observed with F-actin depolymerizing agents in different synapse types and profilin may contribute in both (Pilo Boyl and others 2007; Wagh and others 2015) . SMA mice exhibited an impaired vesicle release accompanied by a reduced number of SVs docked to the membrane indicating a reduced readily releasable pool (Kong and others 2009; Torres-Benito and others 2011) . Interestingly, juxtamembrane F-actin levels were reduced in presynapses of SMA mice (Ackermann and others 2013) . Thus, SV guidance function of the actin cytoskeleton may be impaired. Accordingly, profilin-2 directly interacts with the PLP domain of piccolo, an active zone scaffold protein (Waites and others 2011; Wang and others 1999) . Thus, spatial F-actin polymerization facilitates parallel fibers. This oriented polymerization is linked to SV transfer from the recycling to the readily releasable pool (Wagh and others 2015) . Thus, defects in profilin function could account for SV release deficiencies in SMA. Supporting this, plastin-3 overexpression could partially rescue vesicle release deficiencies in SMA mice, again stressing the importance of this modifier with regard to profilin-related actin dynamics (Ackermann and others 2013) . However, hints for a diminished recycling pool in SMA mice argue for additional mechanisms for synaptic dysfunction (Torres-Benito and others 2011).
Synaptic Vesicle Recycling
Profilin-1 and -2 do not only associate with ROCK and actin binding proteins but also with proteins involved in the regulation of synaptic endocytosis such as clathrin and dynamin-1 (Witke and others 1998). Interestingly, the interaction profile of profilin-1 in CNS tissue largely differs from those observed in non-neuronal tissues (Witke and others 1998) , thus giving a possible explanation for the ALS phenotype caused by profilin-1 mutants. However, the neuronal profilin-2 is recruited to the membrane by interaction with the PLP domain of de-phosphorylated dynamin-1, a vesicle constricting protein. Subsequently, F-actin and SVs form in the endocytic zone (Gareus and others 2006; Yepes and others 2016) . Thus, F-actin is associated with the transport of the nascent vesicle into the cytosol (Merrifield and others 2002) . Supporting an involvement of endocytosis in SMA, an analysis of modifying genes conserved between invertebrate models revealed several genes involved in this process (Dimitriadi and others 2010) . In a Caenorhabditis elegans SMA model, abnormal cisternae were observed at the NMJ, a phenotype associated with defective endocytosis. Moreover, cells with an SMN knockdown had a reduced viral load. Since virus binding was not affected, this hints for an impaired endocytosis (Dimitriadi and others 2016) . Interestingly, defective uptake of dextran beads in SMA could be rescued by plastin-3 overexpression supporting an involvement of the actin cytoskeleton in SMA (Hosseinibarkooie and others 2016) . In ALS, presynaptic pathology has been reported before onset of the disease. SOD1 G93A mice have less SVs but a morphological normal postsynapse, indicating a preferential degeneration of the presynapse (Narai and others 2009). Moreover, neuromuscular transmission was already presynaptically impaired in those mice (Rocha and others 2013) . However, a strong link to the actin cytoskeleton has not been established yet.
Postsynaptic Mechanisms
Profilin is also an important regulator of postsynaptic stability and dynamics, which is impaired at central synapses at the motoneuron cell bodies in SMA (Martinez and others 2012; Mentis and others 2011) (Fig. 4B) . Both profilin proteins locate to postsynaptic structures (Murk and others 2012) with enrichment in dendritic spine heads on either glutamate or electrical stimulation. Thus, accumulation of profilin-2 was more pronounced than profilin-1 enrichment. After stimulation, profilin facilitates spine stabilization via its PLP binding domain (Ackermann and Matus 2003) . Profilin-2 hyperphosphorylation with a reduced PLP-binding capacity may thus serve as an explanation for synapse stripping in SMA (Nolle and others 2011) . Consistent with its positive role in spine formation, knockdown of profilin-2 led to a reduced number of spines. This could be rescued by profilin-1 overexpression, indicating at least partial functional overlap of profilin-1 and -2 in the postsynapse (Michaelsen and others 2010) . However, hippocampal cells transfected with an ALS profilin-1 mutant exhibited enhanced numbers of dendritic spines (Brettle and others 2015) . Notably, those cells were not stimulated and it is possible that enhanced numbers of dendritic spines may lower the cells' adaptive potential when activated. Besides its regulatory activity on synaptic stability, actin is involved in neurotransmitter receptor clustering and trafficking at the post synapse (Kirsch and Betz 1995) . Gephyrin is a scaffolding protein for neurotransmitter receptors important for clustering and synaptic strength. Interestingly, both profilin-1 and profilin-2 bind to this protein and colocalize with it in the rat spinal cord (Giesemann and others 2003; Mammoto and others 1998) . In SMA, an abnormal receptor clustering has been shown at the neuromuscular postsynapse in human fetus predicted to develop SMA (MartinezHernandez and others 2013) . However, a direct link between abnormal postsynaptic receptor clustering and dysregulated actin dynamics has not been reported yet.
Conclusions
Many findings on the molecular and cellular levels point toward an important role of the actin cytoskeleton in motoneuron diseases. Diverse disease phenotypes involve the dysregulation of the dynamic cytoskeleton in ALS and SMA. Thus, synapses require a balanced and spatial regulation of the actin cytoskeleton being involved in synaptic vesicle release at active zones, vesicle uptake at endocytic zones, and trafficking between different vesicle pools. The neuromuscular junction is the largest synapse and may therefore be specifically vulnerable to changes of actin, thus explaining the preferential degeneration of motoneurons. On the molecular level, a network of actin binding proteins and upstream regulators may induce the modified actin dynamics in motoneuron diseases. However, direct interactions of the SMN protein with profilins as well as profilin-1 mutations that cause ALS suggest a central role for this molecule in disease mechanisms. However, many questions remain open (Table 2) . There is still a lack of detailed analyses of profilin-1 and profilin-2 effects on actin dynamics in concert with the SMN protein. It would be interesting to evaluate the precise mechanism of the modulatory activity of SMN on profilins in cell-free assays. Moreover, a comparison of synaptic phenotypes in a profilin-1 ALS mouse with an SMA mouse is of particular interest. Notably, dysregulations in the actin cytoskeleton may represent a common mechanism of both diseases arguing in favor of a coordinated approach bringing together both the ALS and the SMA Field. • Do ALS-linked profilin-1 mutations impair motoneuron function by a gain-of-toxicity mechanism involving aggregate formation, a loss-of-function mechanism or both? • In case of a loss-of-function mechanism: What is the critical function: Profilin's canonical role in actin dynamics or its involvement in stress granule dynamics? Profilin-1 vs. profilin-2
• To which extent do the different profilins contribute to SMA (and ALS)? The role of plastin-3
• Does the modifying activity of plastin-3 rely on profilin's dysfunction in SMA?
• Is plastin-3 a modifier in profilin-1 linked ALS? Cellular mechanisms
• Do mice with an ALS-linked profilin-1 mutation exhibit synaptic phenotypes such as defects in synaptic vesicle mobilization and recycling? • To which extent does profilin-dysfunction explain the functional degeneration phenotypes in SMA motoneurons?
